Search results

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

Australia launched a new international development project in partnership with the International Atomic Energy Agency (IAEA) to advance ‘Rays of Hope’ in the Asia and Pacific region. 

As the flagship facility of ANSTO’s Innovation Precinct at Lucas Heights, nandin recently celebrated its fifth anniversary in a special gathering held this week for its startups, businesses and innovation community.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search for the position.

This instrument can measure reflectivity at air-solid or air-liquid interfaces.

This week ANSTO formally launched the nandin Deep Technology Incubator, a full-service innovation hub that enables the best and the brightest minds to come together to foster innovation and change.

The Australian Synchrotron is a source of powerful X-rays and infrared radiation that can be used for a wide range of scientific and technical purposes. Synchrotron X-rays are millions of times brighter than those produced by conventional X-ray machines in laboratories and hospitals.

Four annual awards in neutron scattering were announced at Australian Neutron Beam Users Group (ANBUG) and AINSE Neutron Scattering Symposium (AANSS) to individuals with strong links to ANSTO

ANSTO shares expertise on food authenticity research using nuclear techniques with Southeast Asia stakeholders.

ANSTO is supporting the introduction of particle therapy, an advanced form of radiation treatment for difficult-to-treat cancers, in Australia

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Fish farming is increasing globally to provide an affordable source of protein and income security for local communities. Joshua's research project aims to optimise production of tilapia to enhance food and nutritional security in PNG.

A 'Challenge-Based Innovation' platform at the nandin Innovation Centre is progressing as part of a funding package from the NSW Government and a Memorandum of Understanding with Swinburne University of Technology and Design Factory Melbourne (DFM).